Sangamo Therapeutics


Sangamo Therapeutics Stock Quote
$8.20 $0.15 1.9%
BATS BZX Real Time Price as of October 11, 2019, 4:00 p.m. EDT View Interactive SGMO Charts

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.

News & Analysis: Sangamo Therapeutics

The Fool has written over 100 articles on Sangamo Therapeutics.


Market Moves


What Happened in the Stock Market Today

Sangamo Therapeutics reported positive data on its gene therapy for hemophilia, and CannTrust Holdings received a noncompliance report from Canadian authorities.

Interactive Chart